Modelling Molecular Mechanisms of Cancer Pathogenesis: Virtual Patients, Real Opportunities

Due to the high number of nonresponders to existing drugs and spiralling costs of new cancer drugs—costs have almost doubled in the last decade, resulting in a dramatic decrease in the number of new drugs—an individualised approach to the diagnosis and treatment of cancer patients is desperately required.